U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Retinoblastoma

MedGen UID:
82965
•Concept ID:
C0278720
•
Neoplastic Process
Synonym: Relapsed Retinoblastoma

Definition

The reemergence of retinoblastoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Retinoblastoma

Professional guidelines

PubMed

Intra-arterial chemotherapy for retinoblastoma treatment in Chile: Experience and results 2013-2020.
Oporto JI, Zúñiga P, Ossandón D, Zanolli M, Pérez V, López JP, Stetcher X, Rodríguez A, Puentes Á, Rustom S, Lobos J
Arch Soc Esp Oftalmol (Engl Ed) 2021 Jun;96(6):288-292. Epub 2021 Feb 27 doi: 10.1016/j.oftale.2020.10.003. PMID: 34092282
OCT-guided management of subclinical recurrent retinoblastoma.
Gaillard MC, Houghton S, Stathopoulos C, Munier FL
Ophthalmic Genet 2018 Jun;39(3):338-343. Epub 2018 Feb 9 doi: 10.1080/13816810.2018.1436183. PMID: 29424610
Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
Shields CL, Kaliki S, Al-Dahmash S, Rojanaporn D, Leahey A, Griffin G, Jabbour P, Shields JA
Retina 2013 Nov-Dec;33(10):2103-9. doi: 10.1097/IAE.0b013e318295f783. PMID: 23873161

Recent clinical studies

Etiology

Outcome of salvage intra-arterial chemotherapy for recurrent retinoblastoma.
Li J, Jing C, Hua X, Liang T, Li J, Zhao P, Ji X
Eye (Lond) 2022 Nov;36(11):2106-2110. Epub 2021 Oct 15 doi: 10.1038/s41433-021-01693-w. PMID: 34654891Free PMC Article
Risk factors for recurrent retinoblastoma after intravenous chemotherapy.
Kaliki S, Vempuluru VS, Priya Y, Mohamed A
Int Ophthalmol 2021 Jun;41(6):2033-2039. Epub 2021 Feb 20 doi: 10.1007/s10792-021-01759-4. PMID: 33611762
Applications of iodine-125 plaque radiotherapy for residual or recurrent retinoblastoma.
Soliman SE, Bansal A, De Nicola ML, Bhambhwani V, Laperriere N, Gallie BL, Krema H
Can J Ophthalmol 2021 Oct;56(5):317-324. Epub 2021 Jan 23 doi: 10.1016/j.jcjo.2020.12.016. PMID: 33493457
OCT-guided management of subclinical recurrent retinoblastoma.
Gaillard MC, Houghton S, Stathopoulos C, Munier FL
Ophthalmic Genet 2018 Jun;39(3):338-343. Epub 2018 Feb 9 doi: 10.1080/13816810.2018.1436183. PMID: 29424610
Periocular topotecan for intraocular retinoblastoma.
Mallipatna AC, Dimaras H, Chan HS, Héon E, Gallie BL
Arch Ophthalmol 2011 Jun;129(6):738-45. doi: 10.1001/archophthalmol.2011.130. PMID: 21670340

Diagnosis

Risk factors for recurrent retinoblastoma after intravenous chemotherapy.
Kaliki S, Vempuluru VS, Priya Y, Mohamed A
Int Ophthalmol 2021 Jun;41(6):2033-2039. Epub 2021 Feb 20 doi: 10.1007/s10792-021-01759-4. PMID: 33611762
Detection of Minimally Visible Recurrent Retinoblastoma by Hand-held Spectral-Domain Optical Coherence Tomography.
Gonzalez-Montpetit ME, Samara WA, Magrath GN, Shields CL
J Pediatr Ophthalmol Strabismus 2017 Feb 14;54:e6-e8. doi: 10.3928/01913913-20170201-03. PMID: 28196267
Very late relapse of bilateral retinoblastoma.
Choi JY, Kang HJ, Lee JW, Ju HY, Hong CR, Kim H, Yu YS, Park SH, Cheon JE, Park KD, Shin HY
J Pediatr Hematol Oncol 2015 May;37(4):e264-7. doi: 10.1097/MPH.0000000000000310. PMID: 25757022
Periocular topotecan for intraocular retinoblastoma.
Mallipatna AC, Dimaras H, Chan HS, Héon E, Gallie BL
Arch Ophthalmol 2011 Jun;129(6):738-45. doi: 10.1001/archophthalmol.2011.130. PMID: 21670340
Cobalt60 plaques in recurrent retinoblastoma.
Fass D, McCormick B, Abramson D, Ellsworth R
Int J Radiat Oncol Biol Phys 1991 Aug;21(3):625-7. doi: 10.1016/0360-3016(91)90679-x. PMID: 1869458

Therapy

Outcome of salvage intra-arterial chemotherapy for recurrent retinoblastoma.
Li J, Jing C, Hua X, Liang T, Li J, Zhao P, Ji X
Eye (Lond) 2022 Nov;36(11):2106-2110. Epub 2021 Oct 15 doi: 10.1038/s41433-021-01693-w. PMID: 34654891Free PMC Article
Intra-arterial chemotherapy for retinoblastoma in 341 consecutive eyes (1,292 infusions): comparative analysis of outcomes based on patient age, race, and sex.
Shields CL, Dockery PW, Yaghy A, Duffner ER, Levin HJ, Taylor OS, Sajjadi Z, Lally SE, Shields JA, Rosenwasser R, Tjoumakaris S, Jabbour P
J AAPOS 2021 Jun;25(3):150.e1-150.e9. Epub 2021 May 24 doi: 10.1016/j.jaapos.2020.12.006. PMID: 34044113
Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
Shields CL, Manjandavida FP, Arepalli S, Kaliki S, Lally SE, Shields JA
JAMA Ophthalmol 2014 Mar;132(3):319-25. doi: 10.1001/jamaophthalmol.2013.7666. PMID: 24407202
Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
Shields CL, Kaliki S, Al-Dahmash S, Rojanaporn D, Leahey A, Griffin G, Jabbour P, Shields JA
Retina 2013 Nov-Dec;33(10):2103-9. doi: 10.1097/IAE.0b013e318295f783. PMID: 23873161
Periocular topotecan for intraocular retinoblastoma.
Mallipatna AC, Dimaras H, Chan HS, Héon E, Gallie BL
Arch Ophthalmol 2011 Jun;129(6):738-45. doi: 10.1001/archophthalmol.2011.130. PMID: 21670340

Prognosis

Characteristics of patients with recurrent retinoblastoma: a survival analysis.
Li N, Wang YZ, Zhang Y, Zhang WL, Huang DS
BMC Cancer 2024 Mar 4;24(1):287. doi: 10.1186/s12885-024-12058-3. PMID: 38438837Free PMC Article
Outcome of salvage intra-arterial chemotherapy for recurrent retinoblastoma.
Li J, Jing C, Hua X, Liang T, Li J, Zhao P, Ji X
Eye (Lond) 2022 Nov;36(11):2106-2110. Epub 2021 Oct 15 doi: 10.1038/s41433-021-01693-w. PMID: 34654891Free PMC Article
Risk factors for recurrent retinoblastoma after intravenous chemotherapy.
Kaliki S, Vempuluru VS, Priya Y, Mohamed A
Int Ophthalmol 2021 Jun;41(6):2033-2039. Epub 2021 Feb 20 doi: 10.1007/s10792-021-01759-4. PMID: 33611762
OCT-guided management of subclinical recurrent retinoblastoma.
Gaillard MC, Houghton S, Stathopoulos C, Munier FL
Ophthalmic Genet 2018 Jun;39(3):338-343. Epub 2018 Feb 9 doi: 10.1080/13816810.2018.1436183. PMID: 29424610
Periocular topotecan for intraocular retinoblastoma.
Mallipatna AC, Dimaras H, Chan HS, Héon E, Gallie BL
Arch Ophthalmol 2011 Jun;129(6):738-45. doi: 10.1001/archophthalmol.2011.130. PMID: 21670340

Clinical prediction guides

Characteristics of patients with recurrent retinoblastoma: a survival analysis.
Li N, Wang YZ, Zhang Y, Zhang WL, Huang DS
BMC Cancer 2024 Mar 4;24(1):287. doi: 10.1186/s12885-024-12058-3. PMID: 38438837Free PMC Article
Risk factors for recurrent retinoblastoma after intravenous chemotherapy.
Kaliki S, Vempuluru VS, Priya Y, Mohamed A
Int Ophthalmol 2021 Jun;41(6):2033-2039. Epub 2021 Feb 20 doi: 10.1007/s10792-021-01759-4. PMID: 33611762
Applications of iodine-125 plaque radiotherapy for residual or recurrent retinoblastoma.
Soliman SE, Bansal A, De Nicola ML, Bhambhwani V, Laperriere N, Gallie BL, Krema H
Can J Ophthalmol 2021 Oct;56(5):317-324. Epub 2021 Jan 23 doi: 10.1016/j.jcjo.2020.12.016. PMID: 33493457
Periocular topotecan for intraocular retinoblastoma.
Mallipatna AC, Dimaras H, Chan HS, Héon E, Gallie BL
Arch Ophthalmol 2011 Jun;129(6):738-45. doi: 10.1001/archophthalmol.2011.130. PMID: 21670340
Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO
Ophthalmology 2004 Oct;111(10):1917-24. doi: 10.1016/j.ophtha.2004.04.016. PMID: 15465557

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...